|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9 GBX | -10.00% |
|
-25.00% | -59.09% |
| Apr. 19 | Redx Pharma shareholders approve AIM delisting plans | AN |
| Apr. 19 | Redx Pharma Gets Shareholder Approval for Delisting from AIM | MT |
Redx Pharma Plc reported earnings results for the full year ended September 30, 2023. For the full year, the company reported sales was GBP 4.2 million compared to GBP 18.69 million a year ago. Net loss was GBP 33.16 million compared to GBP 18.01 million a year ago.
Basic loss per share from continuing operations was GBP 0.099 compared to GBP 0.061 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -59.09% | 43.61M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
REDX PHARMA PLC 
